Lingohr Asset Management GmbH purchased a new position in DocuSign, Inc. (NASDAQ:DOCU – Free Report) in the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The fund purchased 5,864 shares of the company’s stock, valued at approximately $538,000.
A number of other hedge funds and other institutional investors have also bought and sold shares of DOCU. Itau Unibanco Holding S.A. purchased a new position in DocuSign in the 3rd quarter worth approximately $28,000. Kestra Investment Management LLC purchased a new position in DocuSign in the 4th quarter worth approximately $30,000. Brooklyn Investment Group purchased a new stake in shares of DocuSign in the 3rd quarter valued at $33,000. Modus Advisors LLC purchased a new stake in shares of DocuSign in the 4th quarter valued at $36,000. Finally, First Horizon Advisors Inc. boosted its stake in shares of DocuSign by 102.6% in the 4th quarter. First Horizon Advisors Inc. now owns 397 shares of the company’s stock valued at $36,000 after purchasing an additional 201 shares in the last quarter. Hedge funds and other institutional investors own 77.64% of the company’s stock.
DocuSign Price Performance
Shares of DocuSign stock opened at $85.61 on Thursday. The company has a 50-day moving average of $87.67 and a 200 day moving average of $79.91. The firm has a market cap of $17.30 billion, a price-to-earnings ratio of 17.65, a PEG ratio of 6.94 and a beta of 1.02. DocuSign, Inc. has a 1 year low of $48.70 and a 1 year high of $107.86.
Analysts Set New Price Targets
DOCU has been the subject of a number of research reports. Needham & Company LLC reaffirmed a “hold” rating on shares of DocuSign in a research note on Friday, March 14th. Royal Bank of Canada reaffirmed a “sector perform” rating and issued a $90.00 price objective on shares of DocuSign in a research note on Friday, March 14th. JPMorgan Chase & Co. raised shares of DocuSign from an “underweight” rating to a “neutral” rating and upped their price objective for the company from $70.00 to $75.00 in a research note on Monday, March 10th. HSBC reissued a “reduce” rating on shares of DocuSign in a research report on Friday, December 6th. Finally, Bank of America dropped their price target on shares of DocuSign from $112.00 to $98.00 and set a “neutral” rating for the company in a research report on Friday, March 14th. Two research analysts have rated the stock with a sell rating, nine have assigned a hold rating and four have assigned a buy rating to the company’s stock. According to MarketBeat, the company has a consensus rating of “Hold” and a consensus price target of $95.00.
Get Our Latest Stock Report on DOCU
Insider Activity at DocuSign
In related news, Director Teresa Briggs sold 534 shares of the stock in a transaction dated Monday, March 17th. The shares were sold at an average price of $87.41, for a total transaction of $46,676.94. Following the sale, the director now directly owns 8,270 shares of the company’s stock, valued at approximately $722,880.70. This represents a 6.07 % decrease in their position. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, CFO Blake Jeffrey Grayson sold 8,000 shares of the firm’s stock in a transaction dated Friday, February 14th. The shares were sold at an average price of $86.90, for a total transaction of $695,200.00. Following the sale, the chief financial officer now directly owns 77,851 shares in the company, valued at approximately $6,765,251.90. The trade was a 9.32 % decrease in their position. The disclosure for this sale can be found here. In the last ninety days, insiders have sold 66,034 shares of company stock valued at $5,932,352. 1.66% of the stock is owned by insiders.
About DocuSign
DocuSign, Inc provides electronic signature solution in the United States and internationally. The company provides e-signature solution that enables sending and signing of agreements on various devices; Contract Lifecycle Management (CLM), which automates workflows across the entire agreement process; Document Generation streamlines the process of generating new, custom agreements; and Gen for Salesforce, which allows sales representatives to automatically generate agreements with a few clicks from within Salesforce.
Read More
- Five stocks we like better than DocuSign
- What is Put Option Volume?
- What GTC 2025 Signals for NVIDIA Stock’s Next Big Move
- 3 Monster Growth Stocks to Buy Now
- Alphabet’s Officially In A Bear Market—Time To Buy?
- Where Do I Find 52-Week Highs and Lows?
- D-Wave and Quantum Supremacy: Implications For Investors
Want to see what other hedge funds are holding DOCU? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for DocuSign, Inc. (NASDAQ:DOCU – Free Report).
Receive News & Ratings for DocuSign Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DocuSign and related companies with MarketBeat.com's FREE daily email newsletter.